para-hydroxy-l-methamphetamine | 118138-55-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: para-hydroxy-l-methamphetamine
• 英文别名: (-)-p-Hydroxymethamphetamine；4-((R)-2-Methylamino-propyl)-phenol；4-((2R)-2-(Methylamino)propyl)phenol；4-[(2R)-2-(methylamino)propyl]phenol
• CAS: 118138-55-9
• 化学式: C₁₀H₁₅NO
• 分子量: 165.235
• InChiKey: SBUQZKJEOOQSBV-MRVPVSSYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 作用下， 生成 para-hydroxy-l-methamphetamine
  参考文献：
  名称：

  DE683693

  摘要：

  公开号：

文献信息

• Bombesin Analog Peptide Antagonist Conjugates
  申请人：Maecke Helmut

  公开号：US20110097266A1

  公开（公告）日：2011-04-28

  To provide a diagnostic and therapeutic medicament, a bombesin analog peptide antagonist conjugate is provided which has general Formula (I), wherein A is a metal chelator comprising at least one radionuclide metal, B is a spacer linked to N-terminal of C or a covalent bond and C is a bombesin analog peptide antagonist having a sequence as claimed, where further x is an integer from 1 to 3 and n is an integer from 1 to 6. [A-(B) n ] x —C  (I)

  提供一种诊断和治疗药物，该药物是一种炸弹素类似物肽拮抗剂共轭物，具有通式（I），其中A是至少含有一种放射性核素金属的金属螯合剂，B是连接到C的N-末端或共价键的间隔物，C是具有所述序列的炸弹素类似物肽拮抗剂，其中x是1到3的整数，n是1到6的整数。[A-(B)n]x—C  (I)
• Monoclonal antibody to methamphetamine, preparation of the same, assay method and assay kit of methamphetamine
  申请人：UBE INDUSTRIES, LTD.

  公开号：EP0311383B1

  公开（公告）日：1993-10-06
• ANALYTICAL TEST DEVICES FOR COMPETITION ASSAY FOR DRUGS OF NON-PROTEIN ANTIGENS USING IMMUNOCHROMATOGRAPHIC TECHNIQUES
  申请人：DRUG SCREENING SYSTEMS, INC.

  公开号：EP0535133A1

  公开（公告）日：1993-04-07
• EP0535133A4
  申请人：——

  公开号：EP0535133A4

  公开（公告）日：1993-11-24
• DRUG DETECTION KIT AND METHOD
  申请人：Nathaniel Andrew Homer

  公开号：US20080254550A1

  公开（公告）日：2008-10-16

  This invention relates to a kit and to a method of using the kit for the in situ detection of trace quantities of drugs on any surface. The method involves using a sampling means that is purposefully designed to sample trace elements of a drug to sample an unknown drug, chemically reacting the sampled drug with a buffer or digesting solution to produce a composition which is detectable, by immunological techniques. To test the reacted sample it is placed in a well in a detection tablet that has been impregnated with a detecting chemical and produce a visible indication of the presence of absence of a particular drug.